THOMAS DAVIS: Open Payments
NPI 1548320161 · OAKDALE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$243 in 15 payments from 6 companies in 2025. Trend: 2023 $329 · 2024 $224 · 2025 $243
Food & beverage: $243
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $85 |
| Novo Nordisk Inc | 5 | $76 |
| Esperion Therapeutics, Inc. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
Products named: MOUNJARO, Ozempic, NEXLETOL, JARDIANCE, BREZTRI, FANAPT, VRAYLAR, Rybelsus.
Industry payments across LA — which companies pay providers there.
